[Importance of acetylsalicylic acid in primary prevention : ASCEND, ARRIVE and ASPREE as well as a meta-analysis by Rothwell et al]
- PMID: 30645666
- DOI: 10.1007/s00108-018-0541-z
[Importance of acetylsalicylic acid in primary prevention : ASCEND, ARRIVE and ASPREE as well as a meta-analysis by Rothwell et al]
Comment on
-
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.Lancet. 2018 Aug 4;392(10145):387-399. doi: 10.1016/S0140-6736(18)31133-4. Epub 2018 Jul 17. Lancet. 2018. PMID: 30017552 Free PMC article.
-
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.N Engl J Med. 2018 Oct 18;379(16):1529-1539. doi: 10.1056/NEJMoa1804988. Epub 2018 Aug 26. N Engl J Med. 2018. PMID: 30146931 Clinical Trial.
-
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.
-
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.N Engl J Med. 2018 Oct 18;379(16):1519-1528. doi: 10.1056/NEJMoa1803955. Epub 2018 Sep 16. N Engl J Med. 2018. PMID: 30221595 Free PMC article. Clinical Trial.
-
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.N Engl J Med. 2018 Oct 18;379(16):1499-1508. doi: 10.1056/NEJMoa1800722. Epub 2018 Sep 16. N Engl J Med. 2018. PMID: 30221596 Free PMC article. Clinical Trial.
-
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.N Engl J Med. 2018 Oct 18;379(16):1509-1518. doi: 10.1056/NEJMoa1805819. Epub 2018 Sep 16. N Engl J Med. 2018. PMID: 30221597 Free PMC article. Clinical Trial.
Similar articles
-
[Aspirin in primary prevention: the ARRIVE, ASCEND and ASPREE aftermath].G Ital Cardiol (Rome). 2019 Feb;20(2):63-65. doi: 10.1714/3093.30853. G Ital Cardiol (Rome). 2019. PMID: 30747921 Italian. No abstract available.
-
The role of aspirin as antiaggregant therapy in primary prevention. An update.Med Clin (Barc). 2019 Oct 25;153(8):326-331. doi: 10.1016/j.medcli.2019.05.024. Epub 2019 Sep 11. Med Clin (Barc). 2019. PMID: 31521369 Review. English, Spanish.
-
Aspirin in Primary and Secondary Prevention of Cardiovascular Disease.S D Med. 2020 Mar;73(3):130-135. S D Med. 2020. PMID: 32142233
-
Aspirin and Primary Prevention in Patients with Diabetes-A Critical Evaluation of Available Randomized Trials and Meta-Analyses.Thromb Haemost. 2019 Oct;119(10):1573-1582. doi: 10.1055/s-0039-1694774. Epub 2019 Aug 20. Thromb Haemost. 2019. PMID: 31430800 Review.
-
Role of Aspirin for Primary Prevention in Persons with Diabetes Mellitus and in the Elderly.Curr Cardiol Rep. 2020 May 29;22(7):48. doi: 10.1007/s11886-020-01296-z. Curr Cardiol Rep. 2020. PMID: 32472363 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical